![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07F 5/04 | (2006.01) |
A61K 31/69 | (2013.01) | ||
A61K 31/69 | (2006.01) | ||
C07F 5/025 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07B2200/13 | (2013.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3798224 |
(13) | Kind of document | T |
(96) | European patent application number | 20207885.3 |
Date of filing the European patent application | 2017-06-08 | |
(97) | Date of publication of the European application | 2021-03-31 |
(45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201662352787 P | 2016-06-21 | US | |
201662438073 P | 2016-12-22 | US |
(72) |
VALIK, Martin , CZ
GABRIEL, Roman , CZ
VRASPIR, Pavel , CZ
LUKAS, David , CZ
|
(73) |
Assia Chemical Industries LTD ,
Dvora Hanevi'a 124, 6944020 Tel Aviv,
IL
|
(54) | SOLID STATE FORMS OF IXAZOMIB CITRATE |
SOLID STATE FORMS OF IXAZOMIB CITRATE |